Company Filing History:
Years Active: 2024
Title: Nan Shi - Innovator in Oncolytic Virus Vector Technology
Introduction
Nan Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceutical technology, particularly in the development of oncolytic virus vectors. His innovative work aims to enhance cancer treatment methodologies.
Latest Patents
Nan Shi holds a patent for an oncolytic virus vector and its applications. The patent describes a vector that comprises a recombinant nucleic acid, which includes several key components. These components are: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule. This invention has the potential to revolutionize cancer therapies by utilizing the body's immune response.
Career Highlights
Nan Shi is associated with Shanghai Yunying Biopharmaceutical Technology Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and improving patient outcomes in oncology.
Collaborations
Some of his notable coworkers include Ziying Gong and Daoyun Zhang. Their collaborative efforts contribute to the ongoing research and development in the field of biopharmaceuticals.
Conclusion
Nan Shi's contributions to oncolytic virus vector technology exemplify the innovative spirit in the biopharmaceutical industry. His work not only highlights the importance of scientific research but also paves the way for future advancements in cancer treatment.